The molecular weight of chitosan is one of its most determinant characteristics, which 18 affects its processability and its performance as a biomaterial. However, information 19 about the effect of this parameter on the formation of electrosprayed chitosan 20 microcapsules is scarce. In this work, the impact of chitosan molecular weight on its 21 electrosprayability was studied and correlated with its effect on the viscosity, surface 22 tension and electrical conductivity of solutions. A Discriminant Function Analysis 23 revealed that the morphology of the electrosprayed chitosan materials could be correctly 24 predicted using these three parameters for almost 85% of the samples. The suitability of 25 using electrosprayed chitosan capsules as carriers for bioactive agents was also assessed 26 by loading them with a model active compound, (Ð)-epigallocatechin gallate (EGCG) . 27
This encapsulation, with an estimated efficiency of around 80% in terms of preserved 28 antioxidant activity, showed the potential to prolong the antiviral activity of EGCG 29 against murine norovirus via gradual bioactive release combined with its protection 30 against degradation in simulated physiological conditions. 31
Introduction 35
Micro-and nanoencapsulation, processes in which a compound is embedded within a 36 protective matrix (Jiménez-Martín, Gharsallaoui, Pérez-Palacios, Carrascal & Rojas, 37 2014) which is organized in the form of micro-or nanosized structures, have attracted 38 increasing research interest for the protection of sensitive bioactive compounds (Pérez-39
Masiá, López-Nicolás, Periago, Ros, Lagaron & López-Rubio, 2015) and address 40 current concerns related to their formulation, bioavailability or their delivery to specific 41 sites (Zaki, 2014) . Rice-Evans, 1999) was performed in order to quantify the antioxidant activity of both 159 free and encapsulated EGCG, following the protocol described in a previous work 160 
236
The results revealed that there was a small range of Mw-concentration conditions which 237 yielded neat electrosprayed particles under the selected processing parameters. Small 238 deviations from these conditions either caused fiber formation or dripping of the 239 chitosan solutions. As expected, an increase in the molecular weight of chitosan caused 240 a decrease in the concentration at which it could be successfully electrosprayed. The electrical conductivity initially increased with chitosan concentration for the 293 different molecular weights evaluated but eventually showed a maximum for the lower 294
Mw chitosans, i.e. for the solutions where the viscosity allowed evaluation of a wider 295 range of concentrations (cf. Figure 2 ). This can be explained taking into account that the 296 conductivity depends on both the concentration of charges and their mobility. As the 297 concentration of chitosan, and thus of protonated amino groups increased, the 298 conductivity augmented up to a point when the viscosity was so high that the mobility 299 of the charges was hampered. Indeed, these maximum was found at higher 300 concentrations for lower molecular weights. It was interesting to find that the 301 concentration at which each chitosan grade was successfully electrosprayed in the form 302 of neat particles had an electrical conductivity in the increasing slope of the curves, 303 before the maximum, because the viscosity at higher concentrations was too high and 304 gave rise to fibrils. 305 Anyhow, as expected, none of the solution properties could explain the differences in 306 the morphology of the obtained materials on its own. In contrast, a combination of them 307 could help predicting the sprayability of chitosan with a specific molecular weight at a 308 particular concentration. From the different molecular weight Ð concentration combinations which gave rise to 337 fiber-free electrosprayed particles, the chitosan with the lowest assayed molecular 338 weight was selected, as it allowed the highest electrosprayable concentration and thus 339 the greatest productivity. Thus, the chitosan of 25 kDa at 5% (w/v) concentration was 340 selected for further analysis. 341 342
Effect of acetic acid concentration 343
One of the solution parameters that are crucial for the electrohydrodynamic processing 344 of chitosan solutions is the concentration of the acetic acid solution used as solvent. Figure S5 of the Supplementary Material), this dripping could be 366 attributed to a slight decrease in the viscosity of the solutions in combination with a 367 sharp increase in their electrical conductivity at low acetic concentrations, which had 368 already been observed by Zhang and Kawakami (2010) and ascribed to the higher 369 degree of dissociation of the acid at low concentrations. However, a concentration of 370 80% gave rise to more spherical particles with more homogeneous sizes than the 90% 371 used in the previous sections. Having both concentrations the same conductivity, this 372 was attributed to the maximum of viscosity observed at 80% acetic acid (cf. Figure S5  373 of the Supplementary Material), also patent in the cited work (Zhang & Kawakami, 374 2010) although not commented. Therefore, an optimum acetic acid concentration of 375 80% was selected to produce our delivery system. 376
Morphological and chemical characterization of EGCG-loaded capsules 378
The conditions selected in the previous section for the production of electrosprayed 379 chitosan delivery vehicles where used to produce EGCG-loaded chitosan particles with 380 a theoretical EGCG content of 10% w/w of the capsules. Figure 6(a) shows a  381 micrograph of the obtained material, which exhibits a similar morphology as that 382 obtained in the absence of the bioactive compound, although slightly less homogeneous 383 in size. 384 The results showed no significant differences (p<0.05) between the RSA of the 412 unloaded chitosan particles (2.3% ± 0.3%) and that of the solvent blank (2.2% ± 0.4%), 413
suggesting that the polysaccharide exerted no significant antioxidant activity at the 414 assayed concentration. Hence, the potential contribution of the encapsulating matrix to 415 the total antioxidant activity of the EGCG-loaded capsules was neglected. The 416 antioxidant activity of encapsulated EGCG (RSA = 23.0% ± 0.7%) was somewhat 417 lower than that of free EGCG (RSA = 28.9% ± 1.7%) at the same theoretical 418 concentration, implying some bioactivity loss during encapsulation. 419
From these results, the encapsulation efficiency defined by Eq. (2) was estimated to be 420 79.6% ± 2.4%. This considerably high value was consistent with similar encapsulation 421 systems based on chitosan used as delivery vehicles for EGCG (Gómez-Mascaraque, 422
Soler & López-Rubio, 2016). 423 424 3.6. Antiviral activity 425 Table 1 summarizes the results obtained from the antiviral activity assays performed on 426 murine norovirus. While a concentration of 0.25 mg/mL of EGCG was insufficient to 427 observe a significant reduction in the recovered titer of the virus after 2 h of incubation, 428 a concentration of 2.5 mg/mL of the polyphenol did cause a significant reduction, which 429 was statistically lower for the encapsulated compound suggesting that 2 h was 430 insufficient for the complete release of the bioactive. On the contrary, when the viruses 431 were exposed to EGCG overnight, the recovered titer was lower than 1.15 TCID 50 /mL 432 for both free and encapsulated EGCG at 2.5 mg/mL and, more interestingly, the 433 reduction was significantly higher for the encapsulated than for the free flavonoid at 434 0.25 mg/mL. 435 
440
Given that the unloaded electrosprayed chitosan did not show antiviral activity (data not 441 shown), these results can be explained considering that the bioactive compound might 442 have been gradually released from the microcapsules. In fact, a sustained release of 443 bioactives is often desirable and pursued through their encapsulation (Singh, 2010) . In 444 our system, the lower antiviral activity of encapsulated EGCG at short exposure times 445 and its substantial increase at longer time periods suggested a gradual release of the 446 active compound from the chitosan capsules, mainly ascribed to a Fickian diffusion 447 mechanism with some contribution from polymer relaxation phenomena. This result is 448 consistent with the release profiles obtained for similar systems based on EGCG-loaded 449 chitosan microcapsules (Gómez-Mascaraque, Soler & López-Rubio, 2016). On the 450 other hand, the fact that the reduction in the recovered titer was higher for the 451 encapsulated EGCG after an overnight incubation implied that free EGCG was less 452 active against the MNV than the EGCG released from the capsules. As the assay wascarried out in PBS at 37ºC to mimic physiological conditions, this can be easily 454 explained by the great instability of EGCG in slightly alkaline solutions (Sang, 
